Harnessing the Formation of Natural Killer–Tumor Cell Immunological Synapses for Enhanced Therapeutic Effect in Solid Tumors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Harnessing the Formation of Natural Killer–Tumor Cell Immunological Synapses for Enhanced Therapeutic Effect in Solid Tumors
Authors
Keywords
-
Journal
ADVANCED MATERIALS
Volume -, Issue -, Pages 2000020
Publisher
Wiley
Online
2020-04-22
DOI
10.1002/adma.202000020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
- (2018) Li Tang et al. NATURE BIOTECHNOLOGY
- To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
- (2016) F. Danhier JOURNAL OF CONTROLLED RELEASE
- Harnessing NK Cell Memory for Cancer Immunotherapy
- (2016) Todd A. Fehniger et al. TRENDS IN IMMUNOLOGY
- Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials
- (2016) Joseph M. Caster et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Visible light-induced singlet oxygen-mediated intracellular disassembly of polymeric micelles co-loaded with a photosensitizer and an anticancer drug for enhanced photodynamic therapy
- (2015) Gurusamy Saravanakumar et al. CHEMICAL COMMUNICATIONS
- Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells
- (2015) Bonnie Huang et al. Science Translational Medicine
- Cell biological steps and checkpoints in accessing NK cell cytotoxicity
- (2014) Emily M Mace et al. IMMUNOLOGY AND CELL BIOLOGY
- Cancer active targeting by nanoparticles: a comprehensive review of literature
- (2014) Remon Bazak et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Bio-inspired, bioengineered and biomimetic drug delivery carriers
- (2011) Jin-Wook Yoo et al. NATURE REVIEWS DRUG DISCOVERY
- High sensitivity detection of cancer in vivo using a dual-controlled activation fluorescent imaging probe based on H-dimer formation and pH activation
- (2010) Mikako Ogawa et al. Molecular BioSystems
- Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
- (2010) Matthias T Stephan et al. NATURE MEDICINE
- Small-molecule delivery by nanoparticles for anticancer therapy
- (2010) Zhuo (Georgia) Chen TRENDS IN MOLECULAR MEDICINE
- Impact of Nanotechnology on Drug Delivery
- (2009) Omid C. Farokhzad et al. ACS Nano
- Protein nanoparticles as drug carriers in clinical medicine
- (2008) Michael J. Hawkins et al. ADVANCED DRUG DELIVERY REVIEWS
- Natural Killer Cell Accumulation in Tumors Is Dependent on IFN- and CXCR3 Ligands
- (2008) M. Wendel et al. CANCER RESEARCH
- The killer's kiss: the many functions of NK cell immunological synapses
- (2008) Konrad Krzewski et al. CURRENT OPINION IN CELL BIOLOGY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now